Maggie Taylor Davis, PhD

Dr. Margaret (Maggie) Davis is a licensed clinical psychologist and Associate Professor in the Yale Department of Psychiatry (co-appointed in the Department of Psychology). Her research interests center on use of molecular neuroimaging methods to enhance understanding of the relationship between self-injurious behavior (including suicide) and stress-related psychopathology, including BPD. Under her K08 award, she investigated the relationship between availability of mGluR5 (a mostly postsynaptic glutamate receptor involved in the regulation of emotion and pain experience), borderline personality disorder (BPD) symptom presentation, and suicide behaviors. With her current R01 funding from NIMH, the American Foundation for Suicide Prevention, and the Patterson Foundation, Dr. Davis is currently completing studies examining in vivo kappa opioid receptor availability in BPD and PTSD, and evaluating the relationship of these targets to history of suicide behaviors. Ultimately, she hopes to build off these studies and similar work to supplement knowledge concerning the molecular mechanisms subserving stress-related pathology (e.g., BPD, PTSD, eating disordered behavior) and suicide behaviors in service of novel, targeted treatment development.